9 April 2020 The Advanced Manufacturing Growth Centre have created a register seeking expressions of interest from Australian manufacturers and others looking to assist with supply of goods, services or knowledge during the current COVID-19 outbreak. Visit the…
8 April 2020 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), is pleased to inform that EOC Pharma (“EOC”) and Immutep jointly discussed the current AIPAC results and confirmed plans to continue advancing Efti (designated as…
7 April 2020 Murray McDonald, the director of Australian MedTech startup MUVi (Mobile UV innovation) is seeking $200K to produce an additional batch of UV lights to supply Australian hospitals. “We are rapidly scaling up our UV lights…
7 April 2020 Doherty Institute researchers have released their work on COVID-19 modelling to the general public. These models have been utilised by the Commonwealth Government in the public health response to COVID-19. It’s important to note the modelling is…
7 April 2020 Monash scientists are repurposing technology they developed recently to make a rapid test to determine who: has immunity to coronavirus remains infectious is at risk of developing a severe form of the disease. A team,…
7 April 2020 Posted on behalf of Robert Bosch Australia in regards to COVID-19 assistance: “We are designers and builders of manual to automated manufacturing systems, robotics and testing systems which can be used in the manufacturing of anything…
7 April 2020 Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) to develop a potential plasma-derived therapy for treating COVID-19. The alliance will begin immediately with the investigational development of one,…
4 April 2020 With the increasing threat of diseases spreading from animals to humans, including COVID-19, $220m will be directed to upgrading the high containment biosecurity research facility in Geelong, currently testing vaccines to combat the disease. Operated…
6 April 2020 Are you an Australian manufacturer with the capability to produce inputs for COVID-19 RNA extraction? Do you have support to scale up your production? We want to hear from you. Securing Australia’s COVID-19 testing capacity…
3 April 2020 A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint venture of the University of Melbourne and Royal Melbourne Hospital, has shown that…
1 April 2020 Noxopharm (NOX:ASX) announces that the Hudson Institute of Medical Research (Hudson Institute) in Melbourne has identified that idronoxil inhibits a key inflammatory pathway involved in a process known as a cytokine storm. Cytokine storm is…
3 April 2020 This article is republished from The Conversation under a Creative Commons license. Read the original article. Shutterstock Kylie Quinn, RMIT University and Damian Purcell, The Peter Doherty Institute for Infection and Immunity SARS-CoV-2, the virus…